|
|
|
| Effect of Minimally Invasive Stereotactic Soft Channel Hematoma Drainage on Postoperative Neurological Function and Serum Inflammatory Factors in Patients with Hypertensive Basal Ganglia Hemorrhage |
| FENG Le-xiao, SU Yong-yong, XIE Jiang-tao, et al |
| Xianyang Central Hospital,xianyang 712000 |
|
|
|
|
Abstract 【Objective】To investigate the effect of minimally invasive stereotactic soft channel hematoma drainage on postoperative neurological function and serum inflammatory factors in patients with hypertensive basal ganglia hemorrhage. 【Methods】The clinical data of 77 patients with hypertensive basal ganglia hemorrhage admitted to our hospital from June 2018 to June 2020 were retrospectively analyzed. According to the operation scheme, they were divided into traditional group (traditional craniotomy, n=38) and minimally invasive group (minimally invasive stereotactic soft channel hematoma drainage, n=39). The hematoma clearance rate and complications were compared between the two groups, TNF- α, Procalcitonin (PCT), nerve function (NIHSS) and activity of daily living (ADL) were measured.【Results】The hematoma clearance rate of minimally invasive group was better than that of traditional group, and the difference is statistically significant(χ2=1.835,P=0.033＜0.05). One week and one month after operation, TNF -αin the two groups, the PCT level was lower than that before operation, and the minimally invasive group was lower than that of the traditional group, and the difference was statistically significant (P<0.05). The difference of NIHSS and ADL scores in minimally invasive group was higher than that of the traditional group (P<0.05). The incidence of complications in minimally invasive group was 5.12% (2/39), which was lower than that of the traditional group (23.68% (9/38), and the difference was statistically significant(χ2=5.412,P=0.02＜0.05).【Conclusion】Minimally invasive stereotactic soft channel hematoma drainage in patients with hypertensive basal ganglia hemorrhage can reduce the level of serum inflammatory factors, improve the neurological function of patients, and is conducive to the prognosis of patients.
|
|
Received: 05 January 2021
|
|
|
|
|
|
[1] 李刚,刘晓,马俊杰,等.微创钻孔引流术治疗中等量基底核区高血压脑出血的疗效分析及预后的影响[J].立体定向和功能性神经外科杂志,2019,32(5):311-313.
[2] 李超,袁丰,赵浪平,等.微创锥颅软通道置管引流术治疗老年脑挫裂伤患者的临床效果[J].医疗装备,2018,31(23):85-86.
[3] 胡倩,郑丽芳,王希佳,等.神经生长因子与奥拉西坦联合治疗对高血压脑出血患者的应用效果[J].中国临床保健杂志,2018,21(5):644-647.
[4] 张法学,杜晓光,李琛,等.基底核区高血压脑出血手术后患者的生活质量及相关影响因素分析[J].医学临床研究,2018,35(9):1672-1674.[5] 王小卫,王荣辉,冯钰珉,等.微创锥颅软通道引流治疗脑室出血的疗效及安全分析[J].重庆理工大学学报(自然科学),2018,32(12):129-132.
[6] 韩笑.微创锥颅立体定向软通道置管血肿引流术与传统开颅血肿清除术治疗高血压基底核区出血临床效果的对比研究[J].实用心脑肺血管病杂志,2019,27(11):69-72.
[7] 冯良应,钟元冠,林宗保,等.立体定向微创软通道穿刺血肿引流术治疗高血压脑出血对患者神经功能影响[J].中国医师杂志,2020,22(2):281-283.
[8] 韩冲锋.纳洛酮对脑出血患者血清降钙素原及临床疗效的影响[J].贵州医药,2019,43(7):1088-1089.
[9] 谢惠敏.软通道微创穿刺引流术对高血压脑出血患者术后血清MMP-9、PCT水平及生活质量的影响[J].中国民间疗法,2020,28(2):78-79.
[10] 蒋朝晖.原发性高血压患者血清中 T N F‐α 、N F‐κB 的测定与意义[J].医学临床研究,2014,31(3):527-529. |
|
|
|
2021, Vol. 38 
